Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (44)	2/5/2000 3:49:00 AM
From: Mike McFarland	Respond to of 1833

Advanced Assay Technologies for Drug Discovery Living chip technology for drug discovery, T. Kanigan, C. J. Brenan, S. Lafontaine, I. W. Hunter, Massachusetts Institute of Technology {27 January, Advances in Nucleic Acid and Protein Analyses, Manipulation, and Sequencing} spie.org ______ Novel Microfabrication Options for BioMEMS Technologies & Commercialization Strategies CONFERENCE PROCEEDINGS Chapter 10: Living Chip Technology: BioMEMS applied to the creation of cell- based microdevices for drug discovery, cancer screening and toxin detection Dr. Colin Brenan, Postdoctoral Research Associate, Massachusetts Institute of Technology We are developing biosensor technologies based upon arrays of microneedles. Traditional manufacturing techniques, such as silicon MEMs, are unsuitable for producing such high aspect ratio microstructures. As such, we have developed two novel fabrication methods: one which employs microwire and microsink EDM, and another which involves inserting needles into a template with the aid of a magnetic field. knowledgefoundation.com